This inventor holds 4 USPTO granted patents and 5 published patent applications. Top assignee: Uppthera. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2026
Title: Inventor Spotlight: Ji Hoon Ryu
Introduction
Ji Hoon Ryu is a notable inventor based in Seoul, South Korea, recognized for his innovative contributions in the field of biomedical research. With a focus on advancing therapeutic methods, he holds two patents related to compounds that induce selective degradation of polo-like kinase 1 (PLK1), a significant target in cancer treatment.
Latest Patents
His latest patents include the following:
1. **Benzimidazole thiophene derivative compounds inducing selective degradation of PLK1** - This invention provides novel compounds designed to selectively induce the degradation of PLK1. The invention is centered around a bifunctional compound that links a PLK1 binding moiety with an E3 ubiquitin ligase-binding moiety through a chemical linker. It encompasses not only the compound itself but also methods for its preparation and potential applications in preventing or treating diseases related to PLK1.
2. **PLK1 selective degradation inducing compound** - Similar to his first patent, this invention presents compounds that induce selective degradation of PLK1. It focuses on the same bifunctional compound structure, aiming to enhance therapeutic interventions for conditions associated with PLK1 dysregulation.
Career Highlights
Ji Hoon Ryu has made significant strides in his career at Uppthera, a company dedicated to developing groundbreaking therapeutic solutions. His work emphasizes innovation in targeted cancer therapies, positioning him as a vital part of research and development initiatives aimed at combating PLK1-related diseases.
Collaborations
Throughout his career, Ji Hoon has collaborated with notable colleagues such as Si Woo Choi and Soo Hee Ryu. Together, they contribute to the innovative atmosphere at Uppthera, fostering advancements in biomedical applications and patentable inventions.
Conclusion
Ji Hoon Ryu continues to make an impact in the scientific community with his innovative spirit and commitment to developing novel therapeutic solutions. His contributions, particularly through his patented compounds, showcase his dedication to enhancing medical treatments and addressing critical health challenges related to PLK1. His ongoing work at Uppthera promises further advancements in the fight against diseases associated with this important kinase.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile